Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms

Journal of Clinical Microbiology

Volumn 50, Issue 3, 2012, Pages 609-618

  Lorenzetti, Mario Alejandro ^a   Gantuz, Magdalena ^a   Altcheh, Jaime ^a   De Matteo, Elena ^a   Chabay, Paola Andrea ^a   Preciado, María Victoria ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ADOLESCENT; ARTICLE; BENIGN TUMOR; BLOOD CELL; BZLF1 GENE; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GENE DELETION; GENE DOSAGE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS; LYMPHOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SCHOOL CHILD; SECRETION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; TUMOR BIOPSY; VIRUS GENE;

ADOLESCENT; ARGENTINA; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INFECTIOUS MONONUCLEOSIS; LYMPHOMA; MALE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS;

EID: 84857382681     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05778-11     Document Type: Article

References (42)

1. Bentz GL, Whitehurst C, Pagano JS. 2011. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J. Virol. 85:10144-10153.
2. Berger C, et al. 1997. The 30-bp deletion variant of Epstein-Barr virusencoded latent membrane protein-1 prevails in acute infectious mononucleosis. J. Infect. Dis. 176:1370-1373. (Pubitemid 27461006)
3. Chabay P, Burna V, Moar A, Grinstein S. 1999. Prevalencia de la infección por el virus de Epstein-Barr en pacientes pediátricos. Rev. Hospital Ñiños Buenos Aires 41:88-91.
4. Chabay P, De Matteo E, Merediz A, Preciado MV. 2004. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina. Arch. Virol. 149:1515-1526. (Pubitemid 39059505)
5. Chabay P, et al. 2011. Epstein Barr virus in relation to apoptosis markers and patients' outcome in pediatric B-cell non-Hodgkin lymphoma. Cancer Lett. 307:221-226.
6. Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K. 2009. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res. 143:209-221.
7. Chen WG, et al. 1996. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am. J. Pathol. 148:17-23.
8. Correa RM, et al. 2004. Epstein-barr virus (EBV) in healthy carriers: distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. J. Med. Virol. 73:583-588. (Pubitemid 38857209)
9. Correa RM, et al. 2007. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients. J. Med. Virol. 79:401-407. (Pubitemid 46355440)
10. Delecluse HJ, Feederle R, O'Sullivan B, Taniere P. 2007. Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J. Clin. Pathol. 60:1358-1364. (Pubitemid 350247251)
11. Dirnhofer S, et al. 1999. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum. Pathol. 30:781-787. (Pubitemid 29325784)
12. Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N. 1999. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79-95. (Pubitemid 29395060)
13. Edwards RH, Sitki-Green D, Moore DT, Raab-Traub N. 2004. Potential selection of LMP1 variants in nasopharyngeal carcinoma. J. Virol. 78:868-881. (Pubitemid 38067608)
14. Guiretti DM, et al. 2007. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas. J. Med. Virol. 79:1730-1732.
15. Gutierrez MI, et al. 2000. Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients. Leuk. Lymphoma 37:425-429. (Pubitemid 30162553)
16. Gutierrez MI, et al. 1997. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J. Gen. Virol. 78:1663-1670.
17. Hall TA. 1999. BioEdit: a user friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
18. Hayashi K, et al. 1997. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion. Hum. Pathol. 28:1408-1414. (Pubitemid 28013637)
19. Hjalgrim H, Engels EA. 2008. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J. Intern. Med. 264:537-548.
20. Hjalgrim H, et al. 2007. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res. 67:2382-2388. (Pubitemid 46424260)
21. Jin Y, Xie Z, Lu G, Yang S, Shen K. 2010. Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children. Virol. J. 7:92.
22. Kapatai G, Murray P. 2007. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J. Clin. Pathol. 60:1342-1349. (Pubitemid 350252944)
23. Librado P, Rozas J. 2009. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25:1451-1452.
24. Lorenzetti MA, et al. 2010. EBNA1 sequences in Argentinean pediatric acute and latent Epstein-Barr virus infection reflect circulation of novel South American variants. J. Med. Virol. 82:1730-1738.
25. Lorenzetti MA, et al. 2009. Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas. J. Med. Virol. 81:1912-1917.
26. Luzuriaga K, Sullivan JL. 2010. Infectious mononucleosis. N. Engl. J. Med. 362:1993-2000.
27. Mainou BA, Raab-Traub N. 2006. LMP1 strain variants: biological and molecular properties. J. Virol. 80:6458-6468. (Pubitemid 43927448)
28. Miller WE, Edwards RH, Walling DM, Raab-Traub N. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75:2729-2740. (Pubitemid 24303189)
29. Pinto A, et al. 1998. Hodgkin's disease: a disorder of dysregulated cellular cross-talk. Biotherapy 10:309-320. (Pubitemid 28201954)
30. Posada D, Crandall KA. 1998. MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817-818. (Pubitemid 28552116)
31. Rickinson AB, Kieff ED. 2007. Epstein Barr virus, p. 2655-2700. In Knipe DM, et al. (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
32. Saechan V, Mori A, Mitarnun W, Settheetham-Ishida W, Ishida T. 2006. Analysis of LMP1 variants of EBV in southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity. J. Clin. Virol. 36:119-125.
33. Sample J, et al. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:4084-4092. (Pubitemid 20279813)
34. Sandvej K, et al. 1997. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90:323-330. (Pubitemid 27276577)
35. Sitki-Green D, Covington M, Raab-Traub N. 2003. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J. Virol. 77:1840-1847. (Pubitemid 36109996)
36. Sitki-Green DL, Edwards RH, Covington MM, Raab-Traub N. 2004. Biology of Epstein-Barr virus during infectious mononucleosis. J. Infect. Dis. 189:483-492. (Pubitemid 38210585)
37. Swofford DL. 2003. PAUP*. Phylogenetic analysis using parsimony (*and other methods), version 4. Sinauer Associates, Sunderland, MA.
38. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
39. Vetsika EK, Callan M. 2004. Infectious mononucleosis and Epstein-Barr virus. Expert. Rev. Mol. Med. 6:1-16.
40. Walling DM, et al. 1999. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene. J. Infect. Dis. 179:763-774. (Pubitemid 29159320)
41. Wang D, Liebowitz D, Kieff E. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831- 840.
42. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768. (Pubitemid 39331148)